Zydus Lifesciences gets USFDA nod for Celecoxib capsules. The approval includes various strengths of the drug. It will manufacture the drug in Ahmedabad. Celecoxib treats pain and inflammation. US sales for Celecoxib capsules reached $122.6 million. Zydus now has 428 ANDA approvals. A USFDA inspection found two observations at the Matoda facility.
Originally published by The Economic Times https://economictimes.indiatimes.com/markets